These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36607603)

  • 41. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
    Shiraishi T; Nielsen PE
    Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane re-arrangements and rippled phase stabilisation by the cell penetrating peptide penetratin.
    Almeida C; Lamazière A; Filleau A; Corvis Y; Espeau P; Ayala-Sanmartin J
    Biochim Biophys Acta; 2016 Nov; 1858(11):2584-2591. PubMed ID: 27475297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
    Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.
    Bahnsen JS; Franzyk H; Sandberg-Schaal A; Nielsen HM
    Biochim Biophys Acta; 2013 Feb; 1828(2):223-32. PubMed ID: 23085001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. d-Polyarginine Lipopeptides as Intestinal Permeation Enhancers.
    Garcia J; Fernández-Blanco Á; Teixidó M; Sánchez-Navarro M; Giralt E
    ChemMedChem; 2018 Oct; 13(19):2045-2052. PubMed ID: 30063113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin.
    He Z; Liu Z; Tian H; Hu Y; Liu L; Leong KW; Mao HQ; Chen Y
    Nanoscale; 2018 Feb; 10(7):3307-3319. PubMed ID: 29384554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation.
    Åmand HL; Nordén B; Fant K
    Biochem Biophys Res Commun; 2012 Feb; 418(3):469-74. PubMed ID: 22281502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid domain separation, bilayer thickening and pearling induced by the cell penetrating peptide penetratin.
    Lamazière A; Maniti O; Wolf C; Lambert O; Chassaing G; Trugnan G; Ayala-Sanmartin J
    Biochim Biophys Acta; 2010 Dec; 1798(12):2223-30. PubMed ID: 20044976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
    Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
    J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Penetratin story: an overview.
    Dupont E; Prochiantz A; Joliot A
    Methods Mol Biol; 2011; 683():21-9. PubMed ID: 21053119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cell-penetrating peptides on the nasal absorption of insulin.
    Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
    J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model.
    Frøslev P; Franzyk H; Ozgür B; Brodin B; Kristensen M
    Eur J Pharm Sci; 2022 Jan; 168():106054. PubMed ID: 34728364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Penetratin Story: An Overview.
    Dupont E; Prochiantz A; Joliot A
    Methods Mol Biol; 2015; 1324():29-37. PubMed ID: 26202260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early stages of interactions of cell-penetrating peptide penetratin with a DPPC bilayer.
    Pourmousa M; Karttunen M
    Chem Phys Lipids; 2013 Apr; 169():85-94. PubMed ID: 23499547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.
    Rullo A; Qian J; Nitz M
    Biopolymers; 2011 Oct; 95(10):722-31. PubMed ID: 21538329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
    Tamura K; Lee CP; Smith PL; Borchardt RT
    Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
    Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
    Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.